Related Experiment Video
Updated: Sep 14, 2025

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Neonatal Thymic Hemorrhage Secondary to Vitamin K Deficiency: A Case Report
Nicole Asdell1, Cecilie Halling1, Susan M Lopata1
1Division of Neonatology, Nationwide Children's Hospital, Columbus, Ohio, USA.
Introduction:
Vitamin K deficiency bleeding (VKDB) in newborns is a preventable yet serious condition. Maternal malabsorption, such as in Crohn's disease, may impair transplacental vitamin K transfer, increasing neonatal coagulopathy risk.
Case Report:
A 32-year-old woman with Crohn's disease and prior bowel resections delivered at 35+3 weeks due to preeclampsia and fetal distress. Her infant developed severe coagulopathy and a hemorrhagic thymic mass. Laboratory results showed elevated INR and PIVKA-II, which improved with vitamin K and plasma. The mother experienced postpartum hemorrhage and coagulopathy, requiring transfusions, embolization, and vitamin K. Both recovered with treatment. At 13 months, the infant showed only mild left-hand weakness and normal development.
Conclusion:
This case highlights the risk of neonatal VKDB and maternal bleeding due to undiagnosed maternal vitamin K deficiency. Screening and supplementation should be considered in pregnancies affected by malabsorptive disorders like Crohn's disease.
Related Concept Videos
Vitamins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

